Lilly to us is going to emerge as the drug company of the decade.

215

Warner-Lambert is trying to maximize the price paid for the company. They think that they are entitled to a higher price, and this facilitates that.

163

There's isolated incidents of companies (warning) because of patent expiration or pipeline problems or both, but they are very isolated.

117